MACH3 Medical 对比 DigiDictate Mobile 的使用情况和统计数据

MACH3 Medical aids physician efficiency and improves insurance coding accuracy for maximal reimbursement. This allows medical professionals to focus directly on patient care with real-time speech-to-text technology. With this application and service, medical professionals can see more patients and eliminate scribing (dictating), screen time charting, and scrubbing (coding). With MACH3 Medical, users can record meetings, automatically upload recordings fully dictated and receive them off-site by our service to be imputed into the medical professional’s EMR. This reduces the time of upload, charting errors and significantly improves the accuracy of medical insurance billing. Our application can be synchronized with a medical provider’s schedule to allow for accuracy of charting. MACH3 Medical mobile application users generate increased revenues as this service captures all relevant billable patient diagnoses that are sent to medical insurances for reimbursement. Users (medical practices) can expect to increase the income generated from medical insurances by significant percentages, utilizing our MACH3 Medical application. *HIPAA compliant *Dictation, Charting, and scrubbing service included *Medical speech-to-text *3 step review process *Direct communication with our diagnostic nurses and representatives *Full transparency with our billing professionals Mach3 Medical is available on iPad, iPhone, and web. Become a user today and start providing the most efficient patient care with accurate insurance reimbursement! Subscription is required for this service. For more information, visit us at Mach3medical.com
  • Apple 应用商店
  • 免费
  • 生产力

商店排名

- -

DigiDictate-Mobile is a professional dictation application which can be used as a stand-alone recorder or in conjunction with Crescendo’s DigiScribe-XL digital dictation system. The application’s client-centric approach makes it the most comprehensive dictation application available. Manual input of data is eliminated and remote access to server-based data results in constant updates on the progress of work, anytime - anywhere. By taking advantage of, and expanding on, the latest in touch-screen technology, Crescendo ensures that DigiDictate-Mobile is equipped with the easiest navigation system possible. Controlling the dictation is effortless and the application even offers the option of mimicking the slide-switch recording system. As soon as an author starts the application, they are presented with a list of recent activities which contains subject matters that the user has been working on and may need to do additional dictation or research on. Completed, Pending, Most Recent or All dictations are also readily available. All dictation functions are available (record, play, rewind, forward, record over, insert, and delete voice portion) from the interface. Furthermore, a progress bar informs users of how far along they are in the dictation. Likewise, preferred dictation controls (i.e.: the slide switch recording) can be selected. Several options are available once the dictation is complete such as: sign off, discard, suspend or mark as priority. Finally, depending on the author’s configuration for e-mail and cell use, as well as the availability of WiFi, WiMax or Cellular at the time of completion, the file can be uploaded to their central server. > Easy Access to Data and Workflow > Logical Searching of Client Information > Slide-switch Dictation Technology > Suitable for Back-end Voice Recognition > Support for Offline Mode > All Modes of Connectivity are Supported > Real-time Updates > Files Uploaded Based on User Configuration > Large Easy-to-use Buttons Control Dictation > Time Tracker for Simplified Billing
  • Apple 应用商店
  • 免费
  • 生产力

商店排名

- -

MACH3 Medical与DigiDictate Mobile排名比较

对比 MACH3 Medical 与 DigiDictate Mobile 在过去 28 天内的排名趋势

排名

没有可用的数据

MACH3 Medical 对比 DigiDictate Mobile 的排名,按国家/地区比较

对比 MACH3 Medical 与 DigiDictate Mobile 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
MACH3 Medical VS.
DigiDictate Mobile

十二月 23, 2024